Sophie E Waller1, Hugo Morales-Briceño1,2, Laura Williams1, Shekeeb S Mohammad3, Avi Fellner4,5,6, Kishore R Kumar2,6,7, Michel Tchan2,8, Victor S C Fung1,2. 1. Movement Disorders Unit, Neurology Department Westmead Hospital Westmead New South Wales Australia. 2. Sydney Medical School University of Sydney Sydney NSW Australia. 3. The Children's Hospital at Westmead Clinical School University of Sydney Westmead New South Wales Australia. 4. Raphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Hospital Petah Tikva Israel. 5. The Neurology Department Rabin Medical Center, Belinson Hospital Petah Tikva Israel. 6. Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research Darlinghurst New South Wales Australia. 7. Molecular Medicine Laboratory and Neurology Department Concord Repatriation General Hospital Concord New South Wales Australia. 8. Department of Clinical Genetics Westmead Hospital Westmead New South Wales Australia.
Abstract
BACKGROUND: Variants in EIF2AK2 have been recently associated with a spectrum of neurological disease encompassing isolated dystonia to fever-related neurological decompensation, movement disorders and leukodystrophy. CASE: A 32-year old patient presented with childhood-onset episodes of neurological decompensation after febrile illness, progressive anarthria, dystonia and spasticity. The T2/FLAIR MRI showed bilateral posterolateral putamen hyperintensities and white matter changes suggestive of leukodystrophy. Initial extensive metabolic workup and whole genome sequencing (WGS) was unremarkable. Re-analysis of the WGS data revealed a variant in exon 3 of the EIF2AK2 gene [(NM_001135651.3): c.92C > G (p.Pro31Arg)]. EIF2AK2-associated disorders should be incorporated into the differential diagnosis of the syndrome of fever-related neurological decompensation with movement disorders, especially in the presence of abnormal neuroimaging. LITERATURE REVIEW: Disease-causing variants in EIF2AK2 have been reported in 24 individuals from 16 families in the literature to date. Two broad phenotypes have been described, including: (1) childhood-onset generalized dystonia and a normal brain MRI; and (2) early childhood-onset developmental delay combined with movement disorders, spasticity, and seizures in some. Notably, 92% of these patients have neurological deterioration after febrile illness or other physiological stress. Hypomyelination or delayed myelination and thin corpus callosum are seen in most patients and lower medullary lessions are common. Basal ganglia lesions have been reported previously in one case. CONCLUSIONS: EIF2AK2-associated disorders should be incorporated into the differential diagnosis of the syndrome of fever-related neurological decompensation with movement disorders, especially in the presence of abnormal neuroimaging.
BACKGROUND: Variants in EIF2AK2 have been recently associated with a spectrum of neurological disease encompassing isolated dystonia to fever-related neurological decompensation, movement disorders and leukodystrophy. CASE: A 32-year old patient presented with childhood-onset episodes of neurological decompensation after febrile illness, progressive anarthria, dystonia and spasticity. The T2/FLAIR MRI showed bilateral posterolateral putamen hyperintensities and white matter changes suggestive of leukodystrophy. Initial extensive metabolic workup and whole genome sequencing (WGS) was unremarkable. Re-analysis of the WGS data revealed a variant in exon 3 of the EIF2AK2 gene [(NM_001135651.3): c.92C > G (p.Pro31Arg)]. EIF2AK2-associated disorders should be incorporated into the differential diagnosis of the syndrome of fever-related neurological decompensation with movement disorders, especially in the presence of abnormal neuroimaging. LITERATURE REVIEW: Disease-causing variants in EIF2AK2 have been reported in 24 individuals from 16 families in the literature to date. Two broad phenotypes have been described, including: (1) childhood-onset generalized dystonia and a normal brain MRI; and (2) early childhood-onset developmental delay combined with movement disorders, spasticity, and seizures in some. Notably, 92% of these patients have neurological deterioration after febrile illness or other physiological stress. Hypomyelination or delayed myelination and thin corpus callosum are seen in most patients and lower medullary lessions are common. Basal ganglia lesions have been reported previously in one case. CONCLUSIONS: EIF2AK2-associated disorders should be incorporated into the differential diagnosis of the syndrome of fever-related neurological decompensation with movement disorders, especially in the presence of abnormal neuroimaging.
Authors: Kishore R Kumar; Ryan L Davis; Michel C Tchan; G M Wali; Neil Mahant; Karl Ng; Katya Kotschet; Sue-Faye Siow; Jason Gu; Zachary Walls; Ce Kang; Gautam Wali; Stan Levy; Chung Sen Phua; Con Yiannikas; Paul Darveniza; Florence C F Chang; Hugo Morales-Briceño; Dominic B Rowe; Alex Drew; Velimir Gayevskiy; Mark J Cowley; Andre E Minoche; Stephen Tisch; Michael Hayes; Sarah Kummerfeld; Victor S C Fung; Carolyn M Sue Journal: Parkinsonism Relat Disord Date: 2019-11-07 Impact factor: 4.891
Authors: Dongxue Mao; Chloe M Reuter; Maura R Z Ruzhnikov; Anita E Beck; Emily G Farrow; Lisa T Emrick; Jill A Rosenfeld; Katherine M Mackenzie; Laurie Robak; Matthew T Wheeler; Lindsay C Burrage; Mahim Jain; Pengfei Liu; Daniel Calame; Sébastien Küry; Martin Sillesen; Klaus Schmitz-Abe; Davide Tonduti; Luigina Spaccini; Maria Iascone; Casie A Genetti; Mary K Koenig; Madeline Graf; Alyssa Tran; Mercedes Alejandro; Brendan H Lee; Isabelle Thiffault; Pankaj B Agrawal; Jonathan A Bernstein; Hugo J Bellen; Hsiao-Tuan Chao Journal: Am J Hum Genet Date: 2020-03-19 Impact factor: 11.025
Authors: Dora Steel; Michael Zech; Chen Zhao; Katy E S Barwick; Derek Burke; Diane Demailly; Kishore R Kumar; Giovanna Zorzi; Nardo Nardocci; Rauan Kaiyrzhanov; Matias Wagner; Arcangela Iuso; Riccardo Berutti; Matej Škorvánek; Ján Necpál; Ryan Davis; Sarah Wiethoff; Kshitij Mankad; Sniya Sudhakar; Arianna Ferrini; Suvasini Sharma; Erik-Jan Kamsteeg; Marina A Tijssen; Corien Verschuuren; Martje E van Egmond; Joanna M Flowers; Meriel McEntagart; Arianna Tucci; Philippe Coubes; Bernabe I Bustos; Paulina Gonzalez-Latapi; Stephen Tisch; Paul Darveniza; Kathleen M Gorman; Kathryn J Peall; Kai Bötzel; Jan C Koch; Tomasz Kmieć; Barbara Plecko; Sylvia Boesch; Bernhard Haslinger; Robert Jech; Barbara Garavaglia; Nick Wood; Henry Houlden; Paul Gissen; Steven J Lubbe; Carolyn M Sue; Laura Cif; Niccolò E Mencacci; Glenn Anderson; Manju A Kurian; Juliane Winkelmann Journal: Ann Neurol Date: 2020-09-21 Impact factor: 10.422
Authors: Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure Journal: Nat Genet Date: 2014-02-02 Impact factor: 38.330
Authors: Allison Gregory; Mitesh Lotia; Suh Young Jeong; Rachel Fox; Dolly Zhen; Lynn Sanford; Jeff Hamada; Amir Jahic; Christian Beetz; Alison Freed; Manju A Kurian; Thomas Cullup; Marlous C M van der Weijden; Vy Nguyen; Naly Setthavongsack; Daphne Garcia; Victoria Krajbich; Thao Pham; Randy Woltjer; Benjamin P George; Kelly Q Minks; Alexander R Paciorkowski; Penelope Hogarth; Joseph Jankovic; Susan J Hayflick Journal: Mol Genet Genomic Med Date: 2019-05-13 Impact factor: 2.183
Authors: Demy J S Kuipers; Wim Mandemakers; Chin-Song Lu; Simone Olgiati; Guido J Breedveld; Christina Fevga; Vera Tadic; Miryam Carecchio; Bradley Osterman; Lena Sagi-Dain; Yah-Huei Wu-Chou; Chiung C Chen; Hsiu-Chen Chang; Shey-Lin Wu; Tu-Hsueh Yeh; Yi-Hsin Weng; Antonio E Elia; Celeste Panteghini; Nicolas Marotta; Martje G Pauly; Andrea A Kühn; Jens Volkmann; Baiba Lace; Inge A Meijer; Krishna Kandaswamy; Marialuisa Quadri; Barbara Garavaglia; Katja Lohmann; Peter Bauer; Niccolò E Mencacci; Steven J Lubbe; Christine Klein; Aida M Bertoli-Avella; Vincenzo Bonifati Journal: Ann Neurol Date: 2020-12-15 Impact factor: 10.422
Authors: Lauren S Vaughn; Kenneth Frederick; Samuel B Burnett; Nutan Sharma; D Cristopher Bragg; Sarah Camargos; Francisco Cardoso; Rekha C Patel Journal: Biomolecules Date: 2022-05-17